Remyelinating strategies for the treatment of multiple sclerosis
- 28 December 2002
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 68 (5) , 361-376
- https://doi.org/10.1016/s0301-0082(02)00105-3
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusionNature, 2002
- SCIP/Oct‐6, Krox‐20, and desert hedgehog mRNA expression during CNS remyelination by transplanted olfactory ensheathing cellsGlia, 2001
- Enhanced proliferation and directed migration of oligodendroglial progenitors co-grafted with growth factor-secreting cellsGlia, 2000
- Endogenous opioid system in developing normal and jimpy oligodendrocytes: ? and ? opioid receptors mediate differential mitogenic and growth responsesGlia, 1998
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Management of Multiple SclerosisNew England Journal of Medicine, 1997
- Glial-cell transplantation and plasticity in the O-2A lineage — implications for CNS repairTrends in Neurosciences, 1995
- Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein geneNeuron, 1994
- Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerveNature, 1977